Featured News

January 10, 2022

Hempsana Signs Custom Manufacturing Agreement with Feel Ventures to Launch ufeelu

Read More
November 29, 2021

Hempsana Announces Commercial Production of CBG

Read More
November 25, 2021

Hempsana Signs Custom Manufacturing Agreement with Cream of the Crop Therapeutics

Read More
July 21, 2021

Hempsana Signs Processing Agreement With New Leaf Canada

Read More
July 15, 2021

Hempsana Holdings Ltd. Commences Trading on the CSE

Read More
April 23, 2021

Stralak Resources Inc. and Hempsana Inc. Enter Into Business Combination Agreement

Toronto, Ontario – April 23, 2021 – Stralak Resources Inc. (“Stralak”) and Hempsana Inc. (“Hempsana”) are pleased to announce that they have entered into a business combination agreement (the “Combination Agreement”) today, whereby Stralak will acquire all the outstanding securities of Hempsana (the “Proposed Transaction”).

Read More
January 19, 2021

Medical Sales Letter Of Intent

Toronto, Ontario - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company") is pleased to announce it has signed a Letter of Intent with Hempsana Inc. ("Hempsana") to develop and manufacture CBD products for distribution to the medical-patient channel.

Read More
May 19, 2020

Hempsana Receives Second Health Canada Licence

Hempsana is pleased to announce that its Goderich Facility received the Standard Processing License from Health Canada, issued under the Cannabis Regulations.

Read More

Product Catalog

Read More
Our Products
Our StoryProductsServicesInvestorsContact